National Hospital Organization Hokkaido Cancer Center

Sapporo, Hokkaido, Japan
Cancer treatment center in Sapporo
2 Chome-3-54 Kikusui 4 Jo, Shiroishi Ward, Sapporo, Hokkaido 003-0804

About National Hospital Organization Hokkaido Cancer Center


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
15
Pfizer
14
Eli Lilly and Company
4
Japan Clinical Oncology Group
3
Puma Biotechnology, Inc.
3
Takeda
3
Amgen
2
Chugai Pharmaceutical
2
Daiichi Sankyo Co., Ltd.
2
Daiichi Sankyo, Inc.
2
Haruhiko Fukuda
2
Total Rows: 20

Clinical Trials at National Hospital Organization Hokkaido Cancer Center


During the past decade, National Hospital Organization Hokkaido Cancer Center conducted 45 clinical trials. In the 10-year time frame, 45 clinical trials started and 20 clinical trials were completed, i.e. on average, 44.4% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 13 clinical trials were completed. i.e. 72.2% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years33339999336699331111440011336622Started TrialsCompleted Trails201520162017201820192020202120220510
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Trial of Drainage With or Without Bleomycin Instillation for Malignant Pericardial Effusion
1999-08-01
2006-11-01
Completed
80
Trial to Evaluate Radiotherapy With or Without CBDCA in Elderly Patients With Non-Small Cell Lung Cancer (JCOG0301)
2003-07-01
2012-02-01
Completed
200
A Study Comparing Irinotecan and Cisplatin (IP) With Etoposide and Cisplatin (EP) Following EP/TRT for LD-SCLC
2002-09-01
2011-09-01
Completed
281
Rituximab+Standard CHOP vs Rituximab+Bi-weekly CHOP for Untreated Stage III/IV Low-grade B-cell Lymphoma (JCOG0203)
2002-09-01
2010-02-01
Completed
300
Elderly NSCLC/D vs DP (JCOG0207)
2003-04-01
2007-04-01
Terminated
230
Efficacy and Safety Study of Argatroban to Treat Heparin-Induced Thrombocytopenia
2005-06-01
2006-09-01
Completed
8
Phase III Study of Docetaxel + S-1 vs. S-1 for Advanced Gastric Cancer
2006-03-01
2010-10-01
Completed
628
Second Line Chemotherapy for S-1 Refractory Advanced Gastric Cancer
2008-03-01
2011-06-01
Completed
300

Rows per page:

1–62 of 62

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "National Hospital Organization Hokkaido Cancer Center" #1 sponsor was "Hoffmann-La Roche" with 15 trials, followed by "Pfizer" with 14 trials sponsored, "Eli Lilly and Company" with 4 trials sponsored, "Japan Clinical Oncology Group" with 3 trials sponsored and "Puma Biotechnology, Inc." with 3 trials sponsored. Other sponsors include 18 different institutions and companies that sponsored additional 20 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "National Hospital Organization Hokkaido Cancer Center" #1 collaborator was "Ministry of Health, Labour and Welfare, Japan" with 5 trials as a collaborator, "Astellas Pharma Inc" with 2 trials as a collaborator, "Japan Lung Cancer Society" with 2 trials as a collaborator, "Korean Cancer Study Group" with 2 trials as a collaborator and "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 19 trials.
Created with Highcharts 11.1.0Top Leading SponsorsHoffmann-La Roche: 15Hoffmann-La Roche: 15Pfizer: 14Pfizer: 14Eli Lilly and Company: 4Eli Lilly and Company: 4Japan Clinical OncologyGroup: 3Japan Clinical OncologyGroup: 3Puma Biotechnology, Inc.: 3Puma Biotechnology, Inc.: 3Takeda: 3Takeda: 3Amgen: 2Amgen: 2Chugai Pharmaceutical: 2Chugai Pharmaceutical: 2Daiichi Sankyo Co., Ltd.: 2Daiichi Sankyo Co., Ltd.: 2Daiichi Sankyo, Inc.: 2Daiichi Sankyo, Inc.: 2

Created with Highcharts 11.1.0Top CollaboratorsMinistry of Health,Labour and Welfare,Japan: 5Ministry of Health,Labour and Welfare,Japan: 5Astellas Pharma Inc: 2Astellas Pharma Inc: 2Japan Lung Cancer Society: 2Japan Lung Cancer Society: 2Korean Cancer Study Group: 2Korean Cancer Study Group: 2Alliance FoundationTrials (AFT): 1Alliance FoundationTrials (AFT): 1AstraZeneca: 1AstraZeneca: 1Breast International Group: 1Breast International Group: 1Chugai Pharmaceutical: 1Chugai Pharmaceutical: 1Daiichi Sankyo Co., Ltd.: 1Daiichi Sankyo Co., Ltd.: 1Daiichi Sankyo, Inc.: 1Daiichi Sankyo, Inc.: 1

Clinical Trials Conditions at National Hospital Organization Hokkaido Cancer Center


According to Clinical.Site data, the most researched conditions in "National Hospital Organization Hokkaido Cancer Center" are "Breast Cancer" (7 trials), "Breast Neoplasms" (7 trials), "Carcinoma, Non-Small-Cell Lung" (5 trials), "Neoplasms" (3 trials) and "Early Breast Cancer" (2 trials). Many other conditions were trialed in "National Hospital Organization Hokkaido Cancer Center" in a lesser frequency.

Clinical Trials Intervention Types at National Hospital Organization Hokkaido Cancer Center


Most popular intervention types in "National Hospital Organization Hokkaido Cancer Center" are "Drug" (58 trials), "Other" (4 trials), "Procedure" (3 trials), "Device" (2 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (8 trials), "Placebo" (8 trials), "Carboplatin" (5 trials), "Cisplatin" (5 trials) and "Docetaxel" (5 trials). Other intervention names were less common.

Clinical Trials Genders at National Hospital Organization Hokkaido Cancer Center


The vast majority of trials in "National Hospital Organization Hokkaido Cancer Center" are 50 trials for "All" genders, 8 trials for "Female" genders and 4 trials for "Male" genders.

Clinical Trials Status at National Hospital Organization Hokkaido Cancer Center


Currently, there are NaN active trials in "National Hospital Organization Hokkaido Cancer Center". undefined are not yet recruiting, 8 are recruiting, 29 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 24 completed trials in National Hospital Organization Hokkaido Cancer Center, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in National Hospital Organization Hokkaido Cancer Center, 9 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 42 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 42Phase 3: 42Phase 2: 13Phase 2: 13Phase 1: 9Phase 1: 9Not Applicable: 1Not Applicable: 1

Created with Highcharts 11.1.0Trials StatusActive, not recruiting: 29Active, not recruiting: 29Completed: 24Completed: 24Recruiting: 8Recruiting: 8Terminated: 1Terminated: 1